FXYD3 and lung carcinoma: The results showed that LET-7i derived from BMSC-EV suppressed the inhibitory effect of DCLK1 on FXYD3 by down-regulating the expression of KDM3A, thus inhibiting the proliferation, migration and invasion of lung cancer cells (2).